AR042355A1 - Compuestos de 2 - aminopirimidina y metodos de obtencion - Google Patents

Compuestos de 2 - aminopirimidina y metodos de obtencion

Info

Publication number
AR042355A1
AR042355A1 ARP030104541A ARP030104541A AR042355A1 AR 042355 A1 AR042355 A1 AR 042355A1 AR P030104541 A ARP030104541 A AR P030104541A AR P030104541 A ARP030104541 A AR P030104541A AR 042355 A1 AR042355 A1 AR 042355A1
Authority
AR
Argentina
Prior art keywords
compound
formula
group
alkyl
aminopirimidine
Prior art date
Application number
ARP030104541A
Other languages
English (en)
Original Assignee
Avecia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229243A external-priority patent/GB0229243D0/en
Priority claimed from GB0303589A external-priority patent/GB0303589D0/en
Priority claimed from GB0318515A external-priority patent/GB0318515D0/en
Application filed by Avecia Ltd filed Critical Avecia Ltd
Publication of AR042355A1 publication Critical patent/AR042355A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Un proceso para la preparación de un compuesto de fórmula (1), que comprende: a) hacer reaccionar un compuesto de fórmula R1-CO-CH2-E con un compuesto de fórmula R2-CHX1X2 en presencia de un compuesto de fórmula R3R4N-C(NH)NH2 y un catalizador, a fin de formar de esta manera una dihidropirimidina; y b) oxidar la dihidropirimidina producida en la etapa a) con el fin de formar el compuesto de fórmula (1), en donde: R1 es H o un grupo alquilo; R2 es H o un grupo alquilo o arilo; R3 y R4 son, cada uno en forma independiente, H, alquilo o arilo, o R3 y R4 se unen para formar, junto con el nitrógeno al cual están unidos, un anillo heterocíclico de 5 a 7 miembros; E es H, un grupo alquilo no sustituido, un grupo arilo o un grupo tomador de electrones; y X1 y X2 son, cada uno en forma independiente, grupos salientes, o X1 y X2 juntos representan =O.
ARP030104541A 2002-12-16 2003-12-10 Compuestos de 2 - aminopirimidina y metodos de obtencion AR042355A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0229243A GB0229243D0 (en) 2002-12-16 2002-12-16 Compounds and process
GB0303589A GB0303589D0 (en) 2003-02-17 2003-02-17 Compounds and process
GB0318515A GB0318515D0 (en) 2003-08-07 2003-08-07 Compounds and process

Publications (1)

Publication Number Publication Date
AR042355A1 true AR042355A1 (es) 2005-06-15

Family

ID=32600665

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104541A AR042355A1 (es) 2002-12-16 2003-12-10 Compuestos de 2 - aminopirimidina y metodos de obtencion

Country Status (23)

Country Link
US (2) US7524955B2 (es)
EP (2) EP2088142A3 (es)
JP (2) JP4579821B2 (es)
KR (1) KR101060215B1 (es)
AR (1) AR042355A1 (es)
AT (1) ATE448209T1 (es)
AU (1) AU2003288443B2 (es)
BR (1) BR0317313A (es)
CA (1) CA2509344C (es)
CY (1) CY1110605T1 (es)
DE (1) DE60330050D1 (es)
DK (1) DK1578731T3 (es)
ES (1) ES2335279T3 (es)
HK (1) HK1080477A1 (es)
IL (1) IL168884A (es)
MX (1) MXPA05006425A (es)
MY (1) MY138051A (es)
NO (2) NO330983B1 (es)
NZ (1) NZ540722A (es)
PT (1) PT1578731E (es)
SI (1) SI1578731T1 (es)
TW (1) TWI322145B (es)
WO (1) WO2004054986A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
DK1417180T3 (da) 2001-07-13 2007-04-10 Astrazeneca Uk Ltd Fremstilling af aminopyrimidinforbindelser
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR20030092446A (ko) * 2002-05-29 2003-12-06 주식회사 한국토종약초연구소 씨형 간염 활성 억제를 갖는 조릿대 추출물을 포함하는조성물
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
DK1578731T3 (da) 2002-12-16 2010-02-15 Astrazeneca Uk Ltd Fremgangsmåde til fremstilling af pyrimidinforbindelser
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US8153791B2 (en) * 2005-12-21 2012-04-10 Janssen Pharmaceutica N.V. Substituted pyrimidinyl oxime kinase inhibitors
WO2007109783A2 (en) * 2006-03-23 2007-09-27 Janssen Pharmaceutica, N.V. Substituted pyrimidine kinase inhibitors
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
WO2011146822A1 (en) 2010-05-21 2011-11-24 Cooper Technologies Company Adapter for bushing latch

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278001A (en) * 1965-02-02 1966-10-11 Charles C Andrews Bearing assembly for auger conveyors
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4689414A (en) * 1986-02-24 1987-08-25 E. R. Squibb & Sons, Inc. 2-(substituted imino)-6-aryl-3,6-dihydro-4-substituted-1,5(2H)-pyrimidinecarboxylic acids and analogs
EP0367895A1 (en) 1988-10-06 1990-05-16 Sandoz Ag Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
FR2665159B1 (fr) 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
WO1993008823A1 (en) 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
JP3197971B2 (ja) 1993-03-01 2001-08-13 塩野義製薬株式会社 ５−カルボアルコキシピリミジン誘導体の合成方法
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
NZ264063A (en) 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
EE9700209A (et) 1994-11-16 1998-04-15 Synaptic Pharmaceutical Corporation Dihüdropürimidiinid ja nende kasutamine
DE19517186A1 (de) * 1995-05-11 1996-11-14 Bayer Ag Verfahren zur Herstellung substituierter 2-Fluor-pyrimidine
FR2741620B1 (fr) 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
AU705409B2 (en) 1995-12-14 1999-05-20 Merck & Co., Inc. Process for making dihydropyrimidinones
US5958934A (en) 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
SE9702563D0 (sv) 1997-07-02 1997-07-02 Astra Ab Compounds
AU8680598A (en) 1997-08-05 1999-03-01 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
GB9903472D0 (en) * 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
EP1193259A4 (en) * 1999-06-23 2003-01-29 Ajinomoto Kk dihydropyrimidine
PL211797B1 (pl) 1999-07-13 2012-06-29 Lonza Ag Sposób wytwarzania 2-amino-4-(4-fluorofenylo)-6-alkilopirymidyno-5-karboksylanu oraz nowe związki pośrednie i sposoby ich wytwarzania
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
WO2001072706A1 (en) 2000-03-28 2001-10-04 Biocon India Limited Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
GB0011163D0 (en) 2000-05-10 2000-06-28 Astrazeneca Ab Chemical compound
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
DK1417180T3 (da) 2001-07-13 2007-04-10 Astrazeneca Uk Ltd Fremstilling af aminopyrimidinforbindelser
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
DK1578731T3 (da) 2002-12-16 2010-02-15 Astrazeneca Uk Ltd Fremgangsmåde til fremstilling af pyrimidinforbindelser
WO2004103977A2 (en) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Process for the preparation of pyrimidine derivatives
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
WO2005063728A2 (en) 2003-12-24 2005-07-14 Teva Pharmaceutical Industries Ltd. Process for preparation of statins with high syn to anti ratio
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
AU2003288443A1 (en) 2004-07-09
EP1578731B1 (en) 2009-11-11
TW200418809A (en) 2004-10-01
TWI322145B (en) 2010-03-21
NO20110366L (no) 2005-07-07
CY1110605T1 (el) 2015-04-29
AU2003288443B2 (en) 2007-10-25
BR0317313A (pt) 2005-11-08
MXPA05006425A (es) 2005-08-19
US20060052604A1 (en) 2006-03-09
WO2004054986A2 (en) 2004-07-01
US20090264654A1 (en) 2009-10-22
ATE448209T1 (de) 2009-11-15
EP2088142A3 (en) 2010-04-21
PT1578731E (pt) 2010-01-12
WO2004054986A3 (en) 2004-12-02
CA2509344A1 (en) 2004-07-01
NO20052781L (no) 2005-07-07
DE60330050D1 (de) 2009-12-24
CA2509344C (en) 2011-10-04
JP2010248222A (ja) 2010-11-04
SI1578731T1 (sl) 2010-02-26
MY138051A (en) 2009-04-30
HK1080477A1 (en) 2006-04-28
KR20050085674A (ko) 2005-08-29
IL168884A (en) 2011-01-31
KR101060215B1 (ko) 2011-08-29
ES2335279T3 (es) 2010-03-24
EP1578731A2 (en) 2005-09-28
WO2004054986A8 (en) 2005-07-21
JP2006515600A (ja) 2006-06-01
NO330983B1 (no) 2011-08-29
EP2088142A2 (en) 2009-08-12
JP4579821B2 (ja) 2010-11-10
JP5318037B2 (ja) 2013-10-16
NZ540722A (en) 2008-03-28
US8273878B2 (en) 2012-09-25
DK1578731T3 (da) 2010-02-15
US7524955B2 (en) 2009-04-28

Similar Documents

Publication Publication Date Title
AR042355A1 (es) Compuestos de 2 - aminopirimidina y metodos de obtencion
ECSP055883A (es) Nuevos derivados de piridazin-3(2h)-ona
WO2006032466A3 (en) New bicyclic antibiotics
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
AR043466A1 (es) Proceso de un solo paso para la preparacion de derivados anticonvulsivos
ES2148120T1 (es) Metodo para la preparacion de citalopram.
CA2613226C (en) Inhibitors of 17beta-hydroxysteroid dehydrogenase type 3
AR053890A1 (es) Proceso para la sintesis de derivados de piridinil-pirimidinilo
AR082864A2 (es) Preparacion de compuestos de aminopirimidina
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
AR045868A1 (es) Proceso para preparar compuestos de ocarbamoilo en presencia de grupo amina activa
NO20064175L (no) Heterosyklisk forbindelse
AR055420A1 (es) Derivados de pirimidina sustituidos
DE602004006965D1 (de) Polymerisationskatalysatoren, organische übergangsmetallverbindungen, verfahren zur herstellung von polyolefinen
KR920006318A (ko) 치환된-4-아미노-3-피리디놀, 이의 제조방법 및 이를 포함하는 약제로서의 이의 용도
EA200401482A1 (ru) Ненуклезидные ингибиторы обратной транскриптазы
AR051991A1 (es) Procedimiento para la preparacion de anilinas
CO4990949A1 (es) Derivados de imidazol y su preparacion .
EA200600551A1 (ru) Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат
NO20031046D0 (no) Fremgangsmåte for fremstilling av en substituert imidazopyridinforbindelse
CO5221077A1 (es) Ariloxipropanolaminas para mejorar la produccion del ganado
RU2010123778A (ru) Процесс
UY27560A1 (es) Compuestos hexaciclicos-
CO5080787A1 (es) Isoquinolinas

Legal Events

Date Code Title Description
FB Suspension of granting procedure